Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Additional Listing

22 May 2007 08:31

Deltex Medical Group PLC22 May 2007 Deltex Medical Group plc Additional Listing Deltex Medical Group plc (the "Company") was notified on 21 May 2007 thatcertain of its European distributors have acquired 800,000 ordinary shares of 1peach at a price of 17.50 pence per share as the result of the exercise of anoption over 800,000 shares granted on 15 December 2005. Accordingly, application has been made for these shares to be admitted totrading on the AIM. The shares will rank pari passu with the existing issuedshares of the Company and dealings are expected to commence on 25 May 2007. Following this, the total number of voting rights in issue will be 84,098,441. 22 May 2007 Enquiries: Deltex Medical Group plc 01243 774 837 Nigel Keen, ChairmanAndy Hill, Chief ExecutiveEwan Phillips, Finance Director Charles Stanley Securities 0207 149 6000 Philip Davies Gavin Anderson Deborah Walter/Marie Cairney/Jodie Reilly 0207 554 1400 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th May 20187:00 amRNSAnnual Report and Notification of AGM
10th May 20187:00 amRNSInvestor Event
9th May 20187:00 amRNSTrueVueTM Loops display launched on CardioQ-ODM+
9th May 20187:00 amRNSResults for the year ended 31 December 2017
25th Apr 20187:00 amRNSNotice of results and FEDORA trial update
7th Mar 20183:51 pmRNSHolding(s) in Company
1st Mar 20187:00 amRNSODM reduces postoperative complications by 75%
20th Feb 20187:00 amRNSCardioQ-ODM+ wins Paris Hospital System Tender
12th Feb 20189:30 amRNSDirector dealing and issue of equity
9th Feb 20181:10 pmRNSResult of General Meeting
9th Feb 201810:12 amRNSResult of Offer and Additional Allotment
24th Jan 20185:17 pmRNSPosting of Circular
23rd Jan 20183:00 pmRNSResult of Oversubscribed Placing
23rd Jan 20187:00 amRNSPlacing, Subscription and Offer
17th Jan 20187:00 amRNSMajor New US Hospital Account
5th Jan 20187:00 amRNSTrading Update
24th Oct 20177:00 amRNSUS launch of TrueVue(TM) system
3rd Oct 20177:00 amRNSNew US hospital account
25th Sep 20177:00 amRNSShare Options
21st Sep 20177:00 amRNSRelease and first sale of HD-ICG in France
11th Sep 20177:00 amRNSInterim Results
31st Aug 20177:00 amRNSNotice of Interim Results
31st Aug 20177:00 amRNSInvestor Event
2nd Aug 201712:59 pmRNSHolding(s) in Company
28th Jul 201711:10 amRNSHolding(s) in Company
27th Jul 20175:24 pmRNSHolding(s) in Company
21st Jul 20177:01 amRNSShare placing
21st Jul 20177:00 amRNSPre-close Trading Update
13th Jun 20179:30 amRNSDirector/PDMR Shareholding
9th Jun 20171:25 pmRNSResult of AGM
9th Jun 20177:00 amRNSExcellent Results from New Trial
9th Jun 20177:00 amRNSAGM Statement
31st May 20177:00 amRNSPatent Grant
26th May 20177:00 amRNSLaunch of ODMV+ system for veterinary anaesthesia
4th May 20177:00 amRNSNew Functionality on CardioQ-ODM+ Monitor Platform
3rd May 20172:20 pmRNSExercise of Options
3rd May 20172:15 pmRNSPublication of Annual Report & Notification of AGM
27th Apr 20177:01 amRNSDeltex awarded EU Horizon 2020 Phase 1 grant
27th Apr 20177:00 amRNSResults for the year ended 31 December 2016
20th Apr 201712:25 pmRNSInvestor open day and notice of results
4th Apr 201711:51 amRNSExercise of Options
28th Mar 20176:05 pmRNSHolding(s) in Company
22nd Mar 20177:15 amRNSGrant of Options
22nd Mar 20177:00 amRNSShare Issues
23rd Feb 20177:00 amRNSNew Monitor Sales in USA and UK
25th Jan 20177:00 amRNSSouth Korean broadens ODM reimbursement
18th Jan 20177:00 amRNSTwo additional US platform programme accounts
18th Jan 20177:00 amRNSTrading Update
30th Nov 20167:00 amRNSAdditional US platform programme account
4th Nov 20167:00 amRNSNHS hospital invests in ODM equipment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.